SequelSEC

Companies spending over 15% of revenue on research

114 companies · latest reported annual period for each

Reported research and development expense against revenue in the latest annual period. Filers that do not report R&D separately are absent rather than counted as zero.

CompanyRevenueNet incomeGross marginFree cash flow
GOOGLAlphabet Inc.$402.84B$132.17B59.7%$73.27B
METAMeta Platforms, Inc.$200.97B$60.46B82.0%$46.11B
ORCLORACLE CORP$67.36B$17.09BUnavailable-$23.69B
MRKMerck & Co., Inc.$65.01B$18.25B74.8%$12.36B
AVGOBroadcom Inc.$63.89BUnavailable67.8%$26.91B
CSCOCISCO SYSTEMS, INC.$63.32B$13.27B64.5%$12.77B
INTCINTEL CORP$52.85B-$267.00M34.8%-$4.95B
BMYBRISTOL MYERS SQUIBB CO$48.19B$7.05B71.1%$12.84B
QCOMQUALCOMM INC/DE$44.28B$5.54B55.4%Unavailable
AMDADVANCED MICRO DEVICES INC$34.64B$4.34B49.5%$6.74B
INTUINTUIT INC.$21.45B$4.57BUnavailable$8.66B
REGNREGENERON PHARMACEUTICALS, INC.$14.34B$4.50BUnavailableUnavailable
NOWServiceNow, Inc.$13.28B$1.75B77.5%$4.58B
NXPINXP Semiconductors N.V.$12.27B$2.02B54.7%$2.42B
ABNBAirbnb, Inc.$12.24B$2.51B83.0%Unavailable
PANWPalo Alto Networks Inc$11.48B$307.00M70.4%Unavailable
ADIANALOG DEVICES INC$11.02B$2.27B61.5%$4.28B
WDAYWorkday, Inc.$9.55B$693.00MUnavailable$2.78B
MRVLMarvell Technology, Inc.$8.19B$2.67B51.0%$1.40B
GRMNGARMIN LTD$7.25B$1.66B58.7%$1.36B
ADSKAutodesk, Inc.$7.21B$1.12B91.0%$2.41B
COIN BankCoinbase Global, Inc.$7.18B$1.26BUnavailableUnavailable
SNPSSYNOPSYS INC$7.05B$1.33B77.0%$1.35B
TEAMAtlassian Corp$6.57B-$53.83M84.8%$1.32B
NTAPNetApp, Inc.$6.24B$1.28B78.5%$1.87B
EWEdwards Lifesciences Corp$6.07B$1.07B78.0%$1.34B
SNAPSnap Inc$5.93B-$460.49M55.0%$437.19M
RIVNRivian Automotive, Inc. / DE$5.39B-$3.65B2.7%-$2.49B
KEYSKeysight Technologies, Inc.$5.38B$850.00M62.1%$1.28B
ONCBeOne Medicines Ltd.$5.34B$286.93M87.5%$941.74M
INCYINCYTE CORP$5.14B$1.29B92.8%Unavailable
TWLOTWILIO INC$5.07B$33.83M48.9%Unavailable
RBLXRoblox Corp$4.89B-$1.07B78.1%$1.36B
ZMZoom Communications, Inc.$4.87B$1.90B77.0%$1.92B
CRWDCrowdStrike Holdings, Inc.$4.81B-$162.50M74.7%$1.31B
CIENCIENA CORP$4.77B$123.34M42.0%$665.29M
ROKUROKU, INC$4.74B$88.36M43.8%$478.44M
MCHPMICROCHIP TECHNOLOGY INC$4.71B$230.00M57.7%$871.00M
SNOWSnowflake Inc.$4.68B-$1.33B67.2%$1.12B
ILMNILLUMINA, INC.$4.34B$850.00M66.1%$931.00M
PINSPINTEREST, INC.$4.22B$416.86M80.1%$1.25B
SWKSSKYWORKS SOLUTIONS, INC.$4.09B$477.10M41.2%$1.11B
CARTMaplebear Inc.$3.74B$447.00M73.7%$910.00M
ALNYALNYLAM PHARMACEUTICALS, INC.$3.71B$313.75M81.8%$465.38M
QRVOQorvo, Inc.$3.68B$338.99M45.9%$679.56M
PEverpure, Inc.$3.66B$188.18M70.4%$615.74M
SOFI BankSoFi Technologies, Inc.$3.61B$481.32M83.1%Unavailable
TRMBTRIMBLE INC.$3.59B$424.00M69.1%$360.90M
DDOGDatadog, Inc.$3.43B$107.74M80.0%$1.00B
ZSZscaler, Inc.$3.35B-$63.18M76.8%$852.35M
BMRNBIOMARIN PHARMACEUTICAL INC$3.22B$348.90M77.7%$724.96M
DOCUDOCUSIGN, INC.$3.22B$309.08M79.4%$1.06B
VEEVVEEVA SYSTEMS INC$3.20B$908.91M75.5%Unavailable
UTHRUNITED THERAPEUTICS Corp$3.18B$1.33B87.9%$1.04B
HUBSHUBSPOT INC$3.13B$45.91M83.8%$707.55M
FFIVF5, INC.$3.09B$692.38M81.4%$906.41M
OKTAOkta, Inc.$2.92B$235.00M77.4%$875.00M
TTDTrade Desk, Inc.$2.90B$443.30M78.6%$795.71M
ETSYETSY INC$2.88B$162.98M71.6%$678.03M
NTNXNutanix, Inc.$2.85B$1.51B86.8%$840.68M

How common this has been

1.0% of companies met this in 2016 and 2.3% in 2025; the share has widened.

YearShareCompanies
20161.0%25 of 2,421
20171.5%44 of 3,029
20181.5%48 of 3,238
20191.6%55 of 3,534
20201.6%62 of 3,849
20211.8%72 of 4,065
20222.0%86 of 4,332
20232.2%100 of 4,573
20242.0%97 of 4,764
20252.3%111 of 4,909

Each year is the screen re-run against the figures each company had reported by that December, so it is what the answer would have been at the time rather than today’s companies with old numbers. The denominator is companies with usable figures that year, which grows as coverage does.

Fiscal year ends differ between companies; each row shows that company’s own latest annual period. Figures are the filers’ own, normalized from their SEC filings.

This screen runs as rd_ratio > 15% AND revenue > 1b. Open it in the screener to change the conditions, or read the methodology for how each figure is chosen.